Answers are grounded in this paper and cite their sources.
Exploratory study reveals cytokine profiles as potential biomarkers in Alzheimer's disease, suggesting therapeutic avenues.
This exploratory study reveals biologically plausible, inflammatory heterogeneity in AD and highlights plasma cytokine profiles as candidate biomarkers and therapeutic targets, warranting investigation.
No takes yet. Share an insight, caveat, or question.
Hussain et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: